FDA OCE and Syapse Announce Research Collaboration Focused on Regulatory Use of Real-World Evidence

Aug 19, 2019 – Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multiyear research collaboration agreement focused on the use of real-world evidence to support regulatory decision-making. Syapse and the OCE will work with stakeholders across the FDA to address key regulatory questions about testing and treatment patterns, dosing and safety, and outcomes in oncology with a focus on precision … (leggi tutto)